Updates are available Correction dated 2025-12-10
Click to view Correction: https://doi.org/10.1038/s41391-025-01064-6
-
Authors
Csizmarik, Anita
Nagy, Nikolett
Keresztes, Dávid
Váradi, Melinda
Bracht, Thilo
Sitek, Barbara
Witzke, Kathrin https://orcid.org/0000-0002-0662-3394
Puhr, Martin https://orcid.org/0000-0002-3858-9653
Tornyi, Ilona https://orcid.org/0000-0003-2165-4196
Lázár, József
Takács, László
Kramer, Gero
Sevcenco, Sabina
Maj-Hes, Agnieszka
Hadaschik, Boris
Nyirády, Péter
Szarvas, Tibor https://orcid.org/0000-0002-6321-0799
- License Information
-
More Information
Article History
Received: 6 January 2023
Revised: 14 July 2023
Accepted: 3 August 2023
First Online: 26 August 2023
Change Date: 8 December 2025
Change Type: Update
Change Details: In Table 2 of this article, the unit for CTAG1A and KLK2 were incorrect and should have read pg/ml and ng/ml respectively.
Change Date: 10 December 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41391-025-01064-6
Competing interests
: BH has had advisory roles for ABX, AAA/Novartis, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Janssen R&D, Lightpoint Medical, Inc., and Pfizer; has received research funding from Astellas, Bristol Myers Squibb, AAA/Novartis, German Research Foundation, Janssen R&D, and Pfizer; and has received compensation for travel from Astellas, AstraZeneca, Bayer and Janssen R&D, all outside the submitted work. The other authors declare no potential conflicts of interest.
: The study was performed in accordance with the ethical standards of the Helsinki Declaration and was approved by the ethical boards of the hospitals (TUKEB 55/2014, ECS 1986/2017). All patients signed consent to an institutional review board-approved protocol before sample collection.
